SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,353 Cr | ₹2,110 Cr | ₹1,967 Cr | ₹1,576 Cr | ₹1,292 Cr |
What is the latest Total Liabilities ratio of SUVEN PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹2,353 Cr |
Mar2023 | ₹2,110 Cr |
Mar2022 | ₹1,967 Cr |
Mar2021 | ₹1,576 Cr |
Mar2020 | ₹1,292 Cr |
How is Total Liabilities of SUVEN PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,353 Cr | 11.52 | |
Mar2023 | ₹2,110 Cr | 7.28 | |
Mar2022 | ₹1,967 Cr | 24.78 | |
Mar2021 | ₹1,576 Cr | 21.97 | |
Mar2020 | ₹1,292 Cr | - |
Compare Total Liabilities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹29,733.5 Cr | 10.7% | 3.4% | 92.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 0.2% | 1% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 6.8% | 1.6% | 53.3% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 4.4% | 2.9% | 4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | -0.7% | 4% | 25.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 4.6% | 4.9% | -6.2% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 10.7% |
3.4% |
92.3% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses